ClinicalTrials.gg
Enrolling by invitationNCT07809035Updated Sep 25, 2026

Climate Change Training for Primary Health Care Workers

An interventional study of scenario-based climate change awareness training. in Climate Change Awareness, sponsored by Maltepe University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to participants aged Up to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-25.

Sponsored by Maltepe University · Not applicable, Interventional, and Health services research

Updated Sep 25, 2026Primary completion movedStudy completion movedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
Up to 65 Years
Sex
All
01

Study summary

Improving climate change awareness among primary care nurses is of great importance for the future of the health sector. Increasing this awareness enables primary care workers to combat environmental health problems more effectively and to adopt a more conscious approach to protecting public health. Climate change is a global public health problem that negatively affects fundamental determinants of health such as clean air, clean drinking water, food, and safe shelter. Nurses, in particular, must understand these environmental risks and develop strategies to ensure the sustainability of health services. The aim of this study is to determine the effect of climate change awareness training given to primary care nurses on their climate change awareness levels.

02

Conditions studied

  • Climate Change Awareness

Keywords

  • climate change
  • primary health care
  • nursing
  • awareness
03

In context

Lead sponsor

Maltepe University is the lead sponsor of 67 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being a nurse or midwife
  • Working in primary care facilities (Family health centers, Migrant health centers, District health directorate)

Exclusion criteria

Exclusion Criteria:

  • To be a medical secretary
  • To work outside of primary care settings
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    The experimental group will receive a one-day training program consisting of three sessions, prepare

    The experimental group will receive a one-day training program consisting of three sessions, prepared by the researchers.Climate change awareness of the experimental group will be measured before, after, and one month after the training.

    Other: scenario-based climate change awareness training.

  • No intervention
    CONTROL GROUP

    limate change awareness of the control group will be measured before, after, and one month after the training, and compared with the experimental group.

Interventions

  • Otherscenario-based climate change awareness training.

    The experimental group will receive a one-day training program consisting of three sessions, prepared by the researchers. The training will be given by the researchers in the conference hall of the district health directorate. Climate change awareness will be measured in both the experimental and control groups before, after, and one month after the training. The control group will also receive training after the intervention.

06

What researchers measure

Primary outcomes

  1. Prior to the intervention, the Climate Change Awareness Scale will be administered to both the experimental and control groups.

    The Climate Change Awareness Scale will be administered prior to the intervention. The scale is a five-point Likert type scale consisting of 52 items and five sub-dimensions: (1) climate change awareness, (2) perception of the problem, (3) knowledge of the causes, (4) level of anxiety, and (5) expectations regarding behaviors and policies. Scores on the scale range from 52 to 260, with higher scores indicating greater awareness of climate change.

    Time frame: pre -intervention

Secondary outcomes

  1. The climate change awareness scale will be administered to both the experimental group and the control group on Day 1, immediately following the intervention.

    The Climate Change Awareness Scale will be administered immediately after the intervention. The scale is a five-point Likert type scale consisting of 52 items and five sub-dimensions: (1) climate change awareness, (2) perception of the problem, (3) knowledge of the causes, (4) level of anxiety, and (5) expectations regarding behaviors and policies.

    Time frame: post intervention first day

Other outcomes

  1. One month after the intervention, the climate change awareness scale will be administered to both the experimental and control groups.

    The Climate Change Awareness Scale will be administered immediately after the intervention. The scale is a five-point Likert type scale consisting of 52 items and five sub-dimensions: (1) climate change awareness, (2) perception of the problem, (3) knowledge of the causes, (4) level of anxiety, and (5) expectations regarding behaviors and policies.

    Time frame: one month after the intervention

07

Study locations

1 site
  • maltepe University
    Maltepe, Büyükbakkalköy Mahallesi, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — In accordance with the informed consent obtained from the participants and the approval of the ethics committee, the data is not permitted to be shared publicly.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Jul 2026 to primary completion in Aug 2026, 1 month.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 25, 2026: primary completion Jul 2026 → Aug 2026 and completion Aug 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 9, 2026
First posted
Sep 9, 2026
StartActual
Jul 30, 2026
Primary completionActual
Aug 30, 2026was Jul 2026
CompletionEst.
Dec 30, 2026was Aug 2026
Last update
Sep 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jul 30, 2026→Aug 30, 2026
Sep 25, 2026
Study completion
Aug 30, 2026→Dec 30, 2026
Sep 25, 2026
Show all 1 update
  1. Sep 25, 2026
    Primary completion Jul 30, 2026→Aug 30, 2026
    Study completion Aug 30, 2026→Dec 30, 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07809035
Lead sponsor
Maltepe University
Responsible party
Emine Ekici (Asisstant Professor, Maltepe University) — Principal investigator
First posted
Sep 9, 2026
Start date
Jul 30, 2026
Primary completion
Aug 30, 2026
Completion
Dec 30, 2026 (estimated)
Last update
Sep 25, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion